These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 19308409

  • 1. Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn.
    Israyelyan A, Shannon EJ, Baghian A, Kearney MT, Kousoulas KG.
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1201-10. PubMed ID: 19308409
    [Abstract] [Full Text] [Related]

  • 2. Herpes simplex virus type-1(HSV-1) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice.
    Israyelyan A, Chouljenko VN, Baghian A, David AT, Kearney MT, Kousoulas KG.
    Virol J; 2008 Jun 02; 5():68. PubMed ID: 18518998
    [Abstract] [Full Text] [Related]

  • 3. Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model.
    Li H, Dutuor A, Fu X, Zhang X.
    J Gene Med; 2007 Mar 02; 9(3):161-9. PubMed ID: 17266169
    [Abstract] [Full Text] [Related]

  • 4. Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus.
    Kohno SI, Luo C, Nawa A, Fujimoto Y, Watanabe D, Goshima F, Tsurumi T, Nishiyama Y.
    Cancer Gene Ther; 2007 Nov 02; 14(11):918-26. PubMed ID: 17693992
    [Abstract] [Full Text] [Related]

  • 5. Thalidomide delayed the ability of 4T1 cells to amass into tumors in Balb/c mice.
    Israyelyan A, Sandoval F, Baghian A, Kearney MT, Shannon EJ.
    Immunopharmacol Immunotoxicol; 2012 Jun 02; 34(3):408-12. PubMed ID: 21942927
    [Abstract] [Full Text] [Related]

  • 6. Combined oncolytic virotherapy with herpes simplex virus for oral squamous cell carcinoma.
    Ogawa F, Takaoka H, Iwai S, Aota K, Yura Y.
    Anticancer Res; 2008 Jun 02; 28(6A):3637-45. PubMed ID: 19189645
    [Abstract] [Full Text] [Related]

  • 7. Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
    Aghi M, Rabkin SD, Martuza RL.
    Cancer Res; 2007 Jan 15; 67(2):440-4. PubMed ID: 17234749
    [Abstract] [Full Text] [Related]

  • 8. Thalidomide attenuates mammary cancer associated-inflammation, angiogenesis and tumor growth in mice.
    Maria de Souza C, Fonseca de Carvalho L, da Silva Vieira T, Cândida Araújo E Silva A, Teresa Paz Lopes M, Alves Neves Diniz Ferreira M, Passos Andrade S, Dantas Cassali G.
    Biomed Pharmacother; 2012 Oct 15; 66(7):491-8. PubMed ID: 22705333
    [Abstract] [Full Text] [Related]

  • 9. Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models.
    Ganesh S, Gonzalez-Edick M, Gibbons D, Van Roey M, Jooss K.
    Clin Cancer Res; 2008 Jun 15; 14(12):3933-41. PubMed ID: 18559615
    [Abstract] [Full Text] [Related]

  • 10. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model.
    Shibata MA, Morimoto J, Shibata E, Otsuki Y.
    Cancer Gene Ther; 2008 Dec 15; 15(12):776-86. PubMed ID: 18654613
    [Abstract] [Full Text] [Related]

  • 11. Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells.
    Israyelyan AH, Melancon JM, Lomax LG, Sehgal I, Leuschner C, Kearney MT, Chouljenko VN, Baghian A, Kousoulas KG.
    Hum Gene Ther; 2007 May 15; 18(5):457-73. PubMed ID: 17536976
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer.
    Ganesh S, Gonzalez-Edick M, Gibbons D, Ge Y, VanRoey M, Robinson M, Jooss K.
    Cancer Gene Ther; 2009 May 15; 16(5):383-92. PubMed ID: 19011598
    [Abstract] [Full Text] [Related]

  • 13. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
    Watanabe D, Goshima F, Mori I, Tamada Y, Matsumoto Y, Nishiyama Y.
    J Dermatol Sci; 2008 Jun 15; 50(3):185-96. PubMed ID: 18226503
    [Abstract] [Full Text] [Related]

  • 14. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL, Smith MJ, Sun BS, Wang GJ, Redmond HP, Wang JH.
    Ann Surg Oncol; 2009 May 15; 16(5):1403-11. PubMed ID: 19263173
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of reovirus therapy combined with cyclophosphamide and gene-modified cell vaccines on tumors induced in mice by HPV16-transformed cells.
    Sobotkova E, Duskova M, Eckschlager T, Vonka V.
    Int J Oncol; 2008 Aug 15; 33(2):421-6. PubMed ID: 18636165
    [Abstract] [Full Text] [Related]

  • 18. Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice.
    Li J, Dong X, Xu Z, Jiang X, Jiang H, Krissansen GW, Sun X.
    J Biomed Sci; 2008 Jan 15; 15(1):99-109. PubMed ID: 17705027
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The therapeutic effect of HSV1-hGM-CSF combined with doxorubicin on the mouse breast cancer model].
    Zhuang XF, Zhang SR, Liu BL, Wu JL, Li XQ, Gu HG, Shu Y.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):178-185. PubMed ID: 29575835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.